Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Loading...
Most Recent Stories

GOLDMAN: HOW TO PLAY THE RIDE UP TO S&P 1525

Despite their recent downgrade of Q1 GDP Goldman Sachs remains incredibly bullish about stocks.  In their most recent strategy note, Goldman highlights the best ways to play the ride up to S&P 1525 (their 12 month target).  They still like what is in essence a fairly aggressive high beta portfolio including BRICs and cyclicals (see here for more on their emerging markets plays):

“Our discussions with clients this week related to our continued pro-cyclical outlook for US equities. The core aspects of our positive outlook for US stocks remain in place. However, the distribution around our base case has widened since early December following a 9% rally in the S&P 500 and elevated risk to the US economic outlook from higher oil prices and inflation. Accordingly, we have shifted our recommended sector weights closer to benchmark and adjusted our thematic trade recommendations to gain more exposure to growth markets.

We (1) maintain our S&P 500 year-end 2011 price target of 1500 (+14%); (2) lower our Financials weighting to Neutral from Overweight and reduce the size of our Health Care underweight; and (3) recommend buying stocks with high BRICs sales <GSTHBRIC> and close our Dividend Growth <GSTHDIVG> and Dual Beta <GSTHBETA> trades.

We believe these changes are consistent with portfolio risk reduction during periods of uncertainty. Our S&P 500 3-, 6-, and 12-month price targets: 1375, 1425, and 1525. US Equity Views: New 3-, 6-, and 12-month targets reflect 5%, 8% and 16% returns (April 13, 2011).  Our views reflect expectations of sustained US economic expansion, moderate inflation, and accommodating monetary policy, but recognize the increased risks of slower growth, inflation, higher oil prices, and interest rates. Our DDM-based 12-month target of 1525 reflects a 16% gain from current levels.”

Source: GS

Comments are closed.